Mesa Laboratories: Recent Breakout Noted, But Looks Exhausted On Closer Inspection

Dec. 09, 2022 10:40 AM ETMesa Laboratories, Inc. (MLAB)
Zach Bristow profile picture
Zach Bristow


  • Breakout above 10-month-long downtrend. This has been observed in several names in our universe.
  • Decent upsides versus consensus in the latest quarterly numbers, revenue is up 71% YoY as well.
  • As such, the stock is well-positioned to prevent further downside, but there's not enough premium to harvest, in our opinion.
  • We continue to rate MLAB a hold.

Young female scientist working in laboratory


Investment Summary

As the market continues to roll on hard into the final stages of FY22 a number of small-cap names have bounced from multi-period lows over the past month. One such name in our universe, amongst many, is Mesa Laboratories, Inc. (


Note: Log scale (Data: Updata)


Data: HBI, Refinitiv Eikon, Koyfin


Data: Updata


Data: Updata

This article was written by

Zach Bristow profile picture
Buy side equity strategist conducting a blend of fundamental, technical, long-term analysis across the broad healthcare, commodities and industrials spectrum in developed markets. Helping you position your portfolios for the future is my top priority. Shoot me a message to discuss trade ides or talk portfolio construction. Disclaimer:The opinions expressed in all articles do not constitute as investment advice. Please remember to conduct your own due diligence.

Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.